PIA
COGT icon

Piedmont Investment Advisors’s Cogent Biosciences COGT Stock Holding History

Piedmont Investment Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-16
Closed -$1K – 1301
2018
Q2 		$1K Buy
+16
New +$769 ﹤0.01% 2741

Other funds holding COGT

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Piedmont Investment Advisors's COGT Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Cogent Biosciences (COGT) in Q3 2018, closing a stake of 16 shares — an estimated $1K sold.

Piedmont Investment Advisors first reported a position in COGT in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 48 funds tracked by Wall St. Rank hold COGT as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Cogent Biosciences position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 16 Cogent Biosciences shares in Q3 2018, an estimated $1K.
  • Piedmont Investment Advisors first reported a position in Cogent Biosciences in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Cogent Biosciences position peaked at $1K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.